$GRND Cashflow Statement | Understand Stock

$GRND

$12.94 -$0.18 (1.37%) Close

$GRND Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock-based compensation
(Gain) loss in fair value of warrant liability
Warrants
Forward Purchase Agreement
Total (Gain) loss in fair value of warrant liability

Fair value of private placement warrant in excess of purchase price
Interest earned on investments held in Trust Account
Initial loss on classification of forward purchase agreement liabilities
Initial loss on forward purchase agreement liabilities
Transaction costs allocable to derivatives
Transaction costs allocated to warrant liability
Accrual of premium on debt
Loss on extinguishment on deferred purchase price paid to Kunlun
Amortization of debt discount and issuance costs
Interest income on promissory note from member
Depreciation and amortization
Provision for expected credit losses
Deferred income taxes
Non-cash lease expense
Changes in operating assets and liabilities:
Prepaid expenses
Accrued expenses
Accounts receivable
Prepaid expenses and deferred charges
Other current assets
Other assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Due to/(from) related party
Lease liability
Other liabilities

Net cash provided by operating activities
Investing activities
Purchases of property and equipment
Additions to capitalized software
Additions to capitalized software development costs
Net cash used in investing activities
Financing activities
Proceeds from sale of Units, net of underwriting discounts paid
Proceeds from the exercise of stock options
Proceeds from the exercise of warrants
Proceeds from issuance of debt
Principal payments on debt
Payment of debt issuance costs
Payment for the purchase of equity instruments
Withholding taxes paid on stock-based compensation
Repurchases of common stock under the stock repurchase program
Transaction costs paid in connection with the Business Combination
Payment of related party note payable
Payment of offering costs
Proceeds from sale of Private Placements Warrants
Payment of deferred purchase price to Kunlun
Distributions paid
Proceeds from the repayment of promissory note to a member including interest
Payment of early termination fee related to the extinguishment of debt
Net cash used in financing activities

Net Change in Cash
Net increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of the period
Cash, cash equivalents and restricted cash, end of the period
Supplemental disclosure of cash flow information:
Cash interest paid
Income taxes paid
Supplemental disclosure of non-cash investing activities:
Offering costs included in accrued offering costs
Deferred offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares
Deferred underwriting fee payable
Paycheck Protection Program loan forgiveness
Repurchase of common stock for net settlement of equity awards
Repayment of principal and interest on the promissory note to a member from distributions
Promissory note to Group Holdings in relation to the Distribution (defined below)
Member distributions
Capitalized software development costs accrued but not paid

Supplemental disclosure of non-cash financing activities:
Withholding taxes on stock-based compensation accrued but not paid
Issuance of common stock for the settlement of certain market condition liability-classified equity awards
Issuance of common stock for the settlement of KPI Awards
Issuance of common stock for the cashless exercise of warrants
Issuance of common stock for the exercise of warrants
Reconciliation of cash, cash equivalents and restricted cash
Cash and cash equivalents
Restricted cash

Comments